Bio-Techne (TECH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Bio-Techne (TECH) is Neutral.

The composite score behind that read is -0.06, weighing +0.12 of bullish evidence against -0.28 bearish.

Bio-Techne last closed at $72.46, +0.01% on the session.

Against the IVW growth benchmark the position is -0.79% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

5 graded predictions for TECH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Bio-Techne in the 11th percentile on valuation and the 57th percentile on return on equity, where 100 is best.

Bio-Techne is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $11.36B.

StockMap tracks Bio-Techne as the 14th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Bio-Techne ranks 37th of 41 in the group, against a group median of +0.06.